Rationalising fixed dose combinations for tuberculosis and acquired immunodeficiency syndrome therapy Online publication date: Thu, 04-Nov-2010
by Shivaan Cooppan, Viness Pillay, Yahya E. Choonara, Lisa C. Du Toit, Valence M.K. Ndesendo
International Journal of Biotechnology (IJBT), Vol. 11, No. 3/4, 2010
Abstract: Poorly managed healthcare can be directly attributed to extensive drug regimens. Numerous chronic illnesses and epidemics such as HIV/AIDS and tuberculosis require elaborate drug regimens for efficacious therapeutic outcomes. Various drug delivery systems have been developed to simplify their regimental drug therapy. However, more effective and innovative drug delivery technologies are required to increase patient compliance and provide controlled drug delivery. This review article attempts to provide a concise incursion into the use of fixed dose combinations as a strategy for drug delivery and describes the opportunities and challenges for the treatment of conditions that require chronic suppressive regimental drug therapy.
Online publication date: Thu, 04-Nov-2010
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Biotechnology (IJBT):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email firstname.lastname@example.org